Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Acorda Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 15 | 17 | +2 |
| Shares | 157.6K | 166.4K | +8.81K (+5.6%) |
| Value | $2.33M | $2.13M | −$194.1K (−8.3%) |
New holders (2)
Institutions that held Acorda Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 103 | $1.36K | 0.00% |
| FMR LLC | 9 | $114 | 0.00% |
Sold out (0)
Institutions that held Acorda Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
None.